当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息21(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Interleukin-2 (IL2)
INDICATI
Approved Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 3 Acute diabete complication [ICD-11: 5A2Y]
INDICATI
Phase 2/3 Bipolar disorder [ICD-11: 6A60]
INDICATI
Phase 2/3 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 2 Adrenal cancer [ICD-11: 2D11]
INDICATI
Phase 2 Brain cancer [ICD-11: 2A00]
INDICATI
Phase 2 Immune system disease [ICD-11: 4A01-4B41]
INDICATI
Phase 2 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 2 Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Phase 2 Mature T-cell lymphoma [ICD-11: 2A90]
INDICATI
Phase 2 Mycosis fungoides [ICD-11: 2B01]
INDICATI
Discontinued in Phase 3 Lupus erythematosus [ICD-11: 4A40]